febuxostat has been researched along with Tumor Lysis Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D | 1 |
| Bellos, I; Kontzoglou, K; Pergialiotis, V; Psyrri, A | 1 |
| Berns, JS; Wilson, FP | 1 |
| Iwasaki, H; Kishi, S; Matsuda, Y; Nakamura, T; Ookura, M; Tai, K; Takai, M; Ueda, T; Yamauchi, T; Yoshida, A | 1 |
| Aurer, I; Baldini, S; Borsaru, G; Bosi, A; Capriati, A; Federico, M; Glushko, NL; Grosicki, S; Jakucs, J; Jordan, K; Maggi, CA; Mayer, J; Montesinos, P; Nagy, Z; Pristupa, AS; Rego, EM; Ribera, JM; Ristic, D; Scartoni, S; Simonelli, C; Spina, M | 1 |
| Fujimaki, K; Fujisaki, T; Gemba, K; Goto, T; Kaneko, M; Kawai, Y; Kiguchi, T; Kirito, K; Maemondo, M; Nakajima, A; Okamoto, M; Takeda, K; Tamura, K; Ueda, T | 1 |
| Horii, M; Kobayashi, S; Kurokawa, Y; Yasu, T | 1 |
| Chahine, G; Fayad, F; Ghorra, C; Khalife, N; Khoury, N; Saleh, K | 1 |
2 review(s) available for febuxostat and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Febuxostat administration for the prevention of tumour lysis syndrome: A meta-analysis.
Topics: Allopurinol; Animals; Febuxostat; Gout Suppressants; Humans; Tumor Lysis Syndrome; Uric Acid | 2019 |
Tumor lysis syndrome: new challenges and recent advances.
Topics: Acute Kidney Injury; Allopurinol; Bicarbonates; Buffers; Calcium; Diuretics; Enzyme Inhibitors; Febuxostat; Fluid Therapy; Humans; Hyperkalemia; Hyperphosphatemia; Hyperuricemia; Hypocalcemia; Renal Dialysis; Thiazoles; Tumor Lysis Syndrome; Urate Oxidase | 2014 |
2 trial(s) available for febuxostat and Tumor Lysis Syndrome
| Article | Year |
|---|---|
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout Suppressants; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Risk Factors; Tumor Lysis Syndrome; Uric Acid; Young Adult | 2015 |
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Neoplasms; Thiazoles; Tumor Lysis Syndrome; Uric Acid; Xanthine Oxidase; Young Adult | 2016 |
5 other study(ies) available for febuxostat and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Febuxostat as a Prophylaxis for Tumor Lysis Syndrome in Children with Hematological Malignancies.
Topics: Adolescent; Age Factors; Allopurinol; Antineoplastic Agents; Biomarkers; Child; Child, Preschool; Creatinine; Down-Regulation; Enzyme Inhibitors; Febuxostat; Female; Hematologic Neoplasms; Humans; Induction Chemotherapy; Japan; Male; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Lysis Syndrome; Uric Acid; Xanthine Oxidase | 2017 |
Febuxostat (Adenuric°) and tumour lysis syndrome.
Topics: Febuxostat; Gout Suppressants; Humans; Tumor Lysis Syndrome | 2016 |
Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study.
Topics: Aged; Allopurinol; Antineoplastic Agents; Creatinine; Enzyme Inhibitors; Febuxostat; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Hypoxanthine; Male; Middle Aged; Pilot Projects; Prospective Studies; Thiazoles; Tumor Lysis Syndrome; Uric Acid; Xanthine; Xanthine Oxidase | 2014 |
The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma
.
Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Tumor Lysis Syndrome | 2016 |
Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.
Topics: Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Febuxostat; Gout Suppressants; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Polymyositis; Rhabdomyolysis; Tumor Lysis Syndrome | 2017 |